Antabuse and Restless leg syndrome - a phase IV clinical study of FDA data

Summary:

Restless leg syndrome is reported only by a few people who take Antabuse.

The phase IV clinical study analyzes which people take Antabuse and have Restless leg syndrome. It is created by eHealthMe based on reports of 884 people who have side effects while taking Antabuse from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

884 people reported to have side effects when taking Antabuse.
Among them, 3 people (0.34%) have Restless leg syndrome.


What is Antabuse?

Antabuse has active ingredients of disulfiram. It is often used in alcoholism. eHealthMe is studying from 1,125 Antabuse users for its effectiveness, alternative drugs and more.

What is Restless leg syndrome?

Restless leg syndrome (a powerful urge to move your legs) is found to be associated with 2,283 drugs and 1,646 conditions by eHealthMe.

Number of Antabuse and Restless leg syndrome reports submitted per year:

Could Antabuse cause Restless leg syndrome?

Gender of people who have Restless leg syndrome when taking Antabuse *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Restless leg syndrome when taking Antabuse *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Antabuse *:

  1. Vivitrol: 2 people, 66.67%
  2. Escitalopram: 2 people, 66.67%
  3. Buspar: 2 people, 66.67%
  4. Xanax: 1 person, 33.33%
  5. Seroquel: 1 person, 33.33%
  6. Neurontin: 1 person, 33.33%
  7. Lipitor: 1 person, 33.33%

Common side effects people have besides Restless leg syndrome *:

  1. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 2 people, 66.67%
  2. Malaise (a feeling of general discomfort or uneasiness): 2 people, 66.67%
  3. Vision Blurred: 1 person, 33.33%
  4. Thrombocytopenia (decrease of platelets in blood): 1 person, 33.33%
  5. Stress And Anxiety: 1 person, 33.33%
  6. Memory Loss: 1 person, 33.33%
  7. Insomnia (sleeplessness): 1 person, 33.33%
  8. Disturbance In Attention: 1 person, 33.33%
  9. Agitation (state of anxiety or nervous excitement): 1 person, 33.33%

Common conditions people have *:

  1. Bipolar Disorder (mood disorder): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Antabuse and have Restless leg syndrome?

Check whether Restless leg syndrome is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Antabuse:

Restless leg syndrome treatments and more:

COVID vaccines that are related to Restless leg syndrome:

How severe was Restless leg syndrome and when was it recovered:

Expand to all the drugs that have ingredients of disulfiram:

Common drugs associated with Restless leg syndrome:

All the drugs that are associated with Restless leg syndrome:

Common conditions associated with Restless leg syndrome:

All the conditions that are associated with Restless leg syndrome:

How the study uses the data?

The study uses data from the FDA. It is based on disulfiram (the active ingredients of Antabuse) and Antabuse (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: